Home/Filings/4/0001562180-22-006777
4//SEC Filing

Noblett Karen 4

Accession 0001562180-22-006777

CIK 0001603756other

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 8:23 PM ET

Size

13.2 KB

Accession

0001562180-22-006777

Insider Transaction Report

Form 4
Period: 2022-09-12
Noblett Karen
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-09-12$14.19/sh+18,519$262,78550,118 total
  • Exercise/Conversion

    Common Stock

    2022-09-12$25.82/sh+13,964$360,55064,082 total
  • Sale

    Common Stock

    2022-09-12$78.16/sh32,483$2,538,80031,599 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-09-1218,5192,963 total
    Exercise: $14.19Exp: 2029-01-30Common Stock (18,519 underlying)
  • Exercise/Conversion

    Stock Options (Right to buy)

    2022-09-1213,9646,348 total
    Exercise: $25.82Exp: 2029-12-12Common Stock (13,964 underlying)
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $78.00 to $78.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date.
  • [F3]The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 1, 2023, provided the reporting person remains in continuous service on each vesting date.

Issuer

Axonics, Inc.

CIK 0001603756

Entity typeother

Related Parties

1
  • filerCIK 0001756240

Filing Metadata

Form type
4
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 8:23 PM ET
Size
13.2 KB